SYMBOTIC INC (SYM)

US87151X1019 - Common Stock

23.99  +0.95 (+4.12%)

Premarket: 24.21 +0.22 (+0.92%)

Fundamental Rating

4

SYM gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 132 industry peers in the Machinery industry. SYM scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. SYM is valued quite expensive, but it does show an excellent growth.



1

1. Profitability

1.1 Basic Checks

In the past year SYM has reported negative net income.
SYM had a negative operating cash flow in the past year.
In the past 5 years SYM always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: SYM reported negative operating cash flow in multiple years.

1.2 Ratios

With a Return On Assets value of -0.85%, SYM is not doing good in the industry: 66.92% of the companies in the same industry are doing better.
SYM has a Return On Equity of -6.84%. This is in the lower half of the industry: SYM underperforms 70.00% of its industry peers.
Industry RankSector Rank
ROA -0.85%
ROE -6.84%
ROIC N/A
ROA(3y)-1.41%
ROA(5y)-24.27%
ROE(3y)-9735.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 13.74%, SYM is not doing good in the industry: 84.62% of the companies in the same industry are doing better.
SYM's Gross Margin has improved in the last couple of years.
SYM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.74%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.29%
GM growth 5YN/A

6

2. Health

2.1 Basic Checks

SYM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SYM has been increased compared to 1 year ago.
There is no outstanding debt for SYM. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

SYM has an Altman-Z score of 6.09. This indicates that SYM is financially healthy and has little risk of bankruptcy at the moment.
SYM has a Altman-Z score of 6.09. This is amongst the best in the industry. SYM outperforms 82.31% of its industry peers.
SYM has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 6.09
ROIC/WACCN/A
WACC9.16%

2.3 Liquidity

A Current Ratio of 1.33 indicates that SYM should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.33, SYM is doing worse than 83.08% of the companies in the same industry.
A Quick Ratio of 1.23 indicates that SYM should not have too much problems paying its short term obligations.
SYM has a Quick ratio (1.23) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.23

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.53% over the past year.
The Revenue has grown by 51.94% in the past year. This is a very strong growth!
The Revenue has been growing by 77.99% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)88.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.5%
Revenue 1Y (TTM)51.94%
Revenue growth 3Y92.19%
Revenue growth 5Y77.99%
Sales Q2Q%47.18%

3.2 Future

SYM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 147.85% yearly.
Based on estimates for the next years, SYM will show a very strong growth in Revenue. The Revenue will grow by 26.47% on average per year.
EPS Next Y838.08%
EPS Next 2Y314.13%
EPS Next 3Y188.5%
EPS Next 5Y147.85%
Revenue Next Year32.83%
Revenue Next 2Y30.43%
Revenue Next 3Y25.05%
Revenue Next 5Y26.47%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

SYM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 83.34, SYM can be considered very expensive at the moment.
68.46% of the companies in the same industry are cheaper than SYM, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of SYM to the average of the S&P500 Index (23.73), we can say SYM is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 83.34

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

SYM's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
SYM's earnings are expected to grow with 188.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y314.13%
EPS Next 3Y188.5%

0

5. Dividend

5.1 Amount

No dividends for SYM!.
Industry RankSector Rank
Dividend Yield N/A

SYMBOTIC INC

NASDAQ:SYM (12/20/2024, 8:00:00 PM)

Premarket: 24.21 +0.22 (+0.92%)

23.99

+0.95 (+4.12%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-18 2024-11-18/amc
Earnings (Next)N/A N/A
Inst Owners81.12%
Inst Owner Change6.46%
Ins Owners0.34%
Ins Owner Change0.07%
Market Cap14.09B
Analysts72
Price Target36.43 (51.85%)
Short Float %18.04%
Short Ratio6.06
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-77.99%
Min EPS beat(2)-157.01%
Max EPS beat(2)1.03%
EPS beat(4)2
Avg EPS beat(4)-30.02%
Min EPS beat(4)-157.01%
Max EPS beat(4)69.2%
EPS beat(8)3
Avg EPS beat(8)-51.36%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)13.13%
Min Revenue beat(2)4.83%
Max Revenue beat(2)21.43%
Revenue beat(4)3
Avg Revenue beat(4)6.73%
Min Revenue beat(4)-1.1%
Max Revenue beat(4)21.43%
Revenue beat(8)7
Avg Revenue beat(8)11.79%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-10.86%
PT rev (3m)-14.38%
EPS NQ rev (1m)3.64%
EPS NQ rev (3m)-15.4%
EPS NY rev (1m)-20.83%
EPS NY rev (3m)-19.84%
Revenue NQ rev (1m)1.86%
Revenue NQ rev (3m)-5%
Revenue NY rev (1m)-1.34%
Revenue NY rev (3m)-2.28%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 83.34
P/S 7.88
P/FCF N/A
P/OCF N/A
P/B 71.45
P/tB 72.8
EV/EBITDA N/A
EPS(TTM)-0.04
EYN/A
EPS(NY)0.29
Fwd EY1.2%
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS3.04
BVpS0.34
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.85%
ROE -6.84%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.74%
FCFM N/A
ROA(3y)-1.41%
ROA(5y)-24.27%
ROE(3y)-9735.85%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y49.29%
GM growth 5YN/A
F-Score4
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 179.89%
Cap/Sales 2.36%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.23
Altman-Z 6.09
F-Score4
WACC9.16%
ROIC/WACCN/A
Cap/Depr(3y)206.19%
Cap/Depr(5y)195.83%
Cap/Sales(3y)2.24%
Cap/Sales(5y)3.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%162.5%
EPS Next Y838.08%
EPS Next 2Y314.13%
EPS Next 3Y188.5%
EPS Next 5Y147.85%
Revenue 1Y (TTM)51.94%
Revenue growth 3Y92.19%
Revenue growth 5Y77.99%
Sales Q2Q%47.18%
Revenue Next Year32.83%
Revenue Next 2Y30.43%
Revenue Next 3Y25.05%
Revenue Next 5Y26.47%
EBIT growth 1Y47.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year396.68%
EBIT Next 3Y106.88%
EBIT Next 5Y83.91%
FCF growth 1Y-146.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-125.16%
OCF growth 3YN/A
OCF growth 5YN/A